critical mass' in key international markets, including France, Canada, and Britain, says Michael Tong, a senior analyst at Wachovia Capital Markets (WFC), who rates Watson overweight. (Wachovia has done business with Watson.) He believes the acquisition...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Marcial: Generic Lipitor Prospects Spur Watson Pharma
Please enter your email address and password. Not a member? Join now